title: Can NKT cells extinguish smoldering myeloma?
abstract: One of the greatest challenges in all of medicine is to improve on the life of an asymptomatic patient; however, in this issue of Blood, Richter and colleagues share provocative new data taking steps toward accomplishing this goal.
authors: The Ohio State University Comprehensive Cancer Center.
authors: Don M
authors: DM
authors: Benson
mesh_terms: D003713:Dendritic Cells / Q000637:transplantation*; D005260:Female; D005699:Galactosylceramides / Q000627:therapeutic use*; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects*; D000077269:Lenalidomide; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D005699:Galactosylceramides; D013792:Thalidomide; D000077269:Lenalidomide; C103873:KRN 7000